Ru(II)-cyclopentadienyl-derived complexes have been reported to inhibit the MEK/ERK and PI3K/Akt signaling pathways in the colorectal cancer cell lines RKO and SW480 [39]. This evidence concerns the gene AKT1 and colorectal cancer.